RxSight sued for securities fraud by Bleichmar Fonti & Auld LLP.

A lawsuit has been filed against RxSight, Inc. and its senior executives for potential violations of federal securities laws. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased RxSight securities. Investors have until September 22, 2025, to ask the Court to be appointed to lead the case.

Investors in RxSight, Inc. (NASDAQ: RXST) have been notified of a securities fraud class action lawsuit filed against the company and its senior executives. The lawsuit, pending in the U.S. District Court for the Central District of California, alleges violations of the federal securities laws. Investors have until September 22, 2025, to ask the court to be appointed as the lead plaintiff in the case.

The complaint, filed by the Law Offices of Frank R. Cruz, claims that between November 7, 2024, and July 8, 2025, RxSight failed to disclose several material issues to investors. These include "adoption challenges" and structural issues that led to declines in sales and utilization of the company's Light Adjustable Lens (LAL) products [1]. Additionally, the complaint alleges that RxSight overstated the demand for its products and provided misleading statements about its business prospects [1].

The lawsuit further claims that as a result of these omissions and misrepresentations, investors suffered damages. On April 3, 2025, and July 8, 2025, RxSight revised its 2025 full-year revenue forecast, leading to significant declines in its stock price [2]. The stock price dropped by approximately 38% on both occasions.

Investors who purchased RxSight securities during the relevant period are encouraged to submit their information to the law firms involved in the case. The Law Offices of Frank R. Cruz, Bleichmar Fonti & Auld LLP, and the Rosen Law Firm have all announced their involvement in the lawsuit and have provided contact information for investors to seek more details [1][2][3].

References:

[1] https://www.marketscreener.com/news/rxsight-inc-rxst-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-ce7c50dcdb8ff622
[2] https://www.globenewswire.com/news-release/2025/08/29/3141420/0/en/RXST-SHAREHOLDERS-RxSight-Inc-Investors-may-have-been-Affected-by-Fraud-Contact-BFA-Law-by-September-22-Court-Deadline-NASDAQ-RXST.html
[3] https://www.globenewswire.com/news-release/2025/08/28/3141246/673/en/ROSEN-GLOBAL-INVESTOR-COUNSEL-Encourages-RxSight-Inc-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-RXST.html